EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin) — Jan Tennvall (2007) | RDL Network
In January 2004, EMEA approved 90Y-radiolabelled ibritumomab tiuxetan, Zevalin, in Europe for the treatment of adult patients with rituximab-relapsed or -r
Sotirios G. Papageorgiou, Panagiotis Diamantopoulos, Georgia Levidou, Maria K. Angelopoulou, Panagiota Economopoulou, Anna Efthimiou, Nikos Constantinou, Andreas Katsigiannis, Penelope Korkolopoulou, Vassiliki Pappa, Christina Economopoulou, George Georgiou, Maria Dimou, Panagiotis Tsirigotis, Marie‐Christine Kyrtsonis, Ιoannis Kotsianidis, Christina Kalpadakis, Meletios A Dimopoulos, Photis Beris, John Meletis, Gerassimos A. Pangalis,
Discussion(0)
No comments yet. Be the first to comment.